Biotech news continually updated from thousands of sources around the net.
1 hr ago | Merced Sun-Star
The potentially Ebola-related death last week of a Liberian government official whose wife and children live in Minnesota has heightened concerns and inspired a fundraising drive to send medical supplies to Liberia.
1 hr ago | ABC News
An outbreak of Ebola in West Africa may seem like a distant threat to many Americans, but it is causing some to cancel travel plans and stirring fear in Minnesota, which has the largest Liberian immigrant population in the United States.
3 hrs ago | Brandon Sun
Pfizer's second-quarter earnings plunged 79 per cent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion.
4 hrs ago | The Winnipeg Free Press
A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.
5 hrs ago | The Miami Herald
In this Thursday, Feb. 28, 2013 photo, Merck scientist Pascale Nantermet conducts research to discover new HIV drugs in West Point, Pa.
5 hrs ago | Ledger-Enquirer.com
The New York company said Tuesday it earned $2.91 billion, or 45 cents per share, in the quarter.
8 hrs ago | ABC News
A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens.
The East Side towers of the Alexandria Center for Life Science have attracted giant pharmaceutical companies such as Pfizer Inc. and Eli Lilly & Co.
A Danbury company researching better ways to treat diabetes has expanded its funding sources through a stock sale agreement with an investment firm.
Targacept CEO Dr. Stephen Hill says the company is considering how best to make use of its resources after the latest in a string of clinical trial failures.
Italy's Rotonda a Mare was built in 1923 but closed in 2005 for renovations. It reopened a year later, with a beautiful sea-themed mosaic by Enzo Cucchi adorning the entrance.
An increase in spider-bite patients at Vanderbilt University Medical Center here has created some concern - but not about an influx of brown recluse spiders in garages or bathroom cabinets.
Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.
Inflation is mild? That's what the government says, but investors paying attention to earnings calls are hearing something they haven't heard in a awhile: Some bold companies are raising prices.
On July 15, Janet Yellen made news with her semiannual policy testimony to Congress, with her views on interest rates, bubbles and the debt market.
Wockhardt Ltd, which denied stake-sale rumours on Friday following an unusual spurt in its stock price, is in the final stages of receiving much-awaited regulatory approvals for its Chikalthana unit in Maharashtra.
Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s.
Updated: Tue Jul 29, 2014 09:17 am
Copyright © 2014 Topix LLC